title: Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects.
authors.affiliation: Utah Transplantation Affiliated Hospitals (UTAH), Cardiac Transplant Program, Salt Lake City.
authors.forename: G D
authors.initials: GD
authors.lastname: Price
authors.forename: S L
authors.initials: SL
authors.lastname: Olsen
authors.forename: D O
authors.initials: DO
authors.lastname: Taylor
authors.forename: J B
authors.initials: JB
authors.lastname: O'Connell
authors.forename: M R
authors.initials: MR
authors.lastname: Bristow
authors.forename: D G
authors.initials: DG
authors.lastname: Renlund
mesh_terms: D003327:Coronary Disease / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced; D006973:Hypertension / Q000139:chemically induced; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects*; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects*; D012189:Retrospective Studies; D013375:Substance Withdrawal Syndrome; D015430:Weight Gain
chemical_list: D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone